tm
Seeing Is Believing
tm
Seeing Is Believing
IPHA is currently covered by 3 analysts with an average price target of $7.57. This is a potential upside of $5.98 (376.1%) from yesterday's end of day stock price of $1.59.
Innate Pharma's activity chart (see below) currently has 23 price targets and 36 ratings on display. The stock rating distribution of IPHA is 14.29% HOLD and 85.71% BUY.
Analysts average stock forecasts to be materialized ratio is 7.08% with an average time for these price targets to be met of 19.4 days.
Highest price target for IPHA is $9, Lowest price target is $5, average price target is $7.57.
Most recent stock forecast was given by JEET MUKHERJEE from BTIG on 17-Sep-2026. First documented stock forecast 14-Dec-2020.
Currently out of the existing stock ratings of IPHA, 1 are a HOLD (14.29%), 6 are a BUY (85.71%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Mar-2026
$9
$7.44 (476.92%)
$9
20 days ago
(17-Sep-2026)
0/3 (0%)
$7.09 (371.20%)
Buy Since 07-Apr-2026
$7
$5.44 (348.72%)
$5
1 months 27 days ago
(10-Aug-2026)
0/11 (0%)
$4.78 (215.32%)
Buy Since 28-Jul-2025
$8
$6.21 (346.93%)
$8
11 months 8 days ago
(29-Oct-2025)
0/2 (0%)
$5.93 (286.47%)
Buy Since 23-Oct-2025
$8
$6.21 (346.93%)
11 months 14 days ago
(23-Oct-2025)
0/1 (0%)
$5.81 (265.30%)
Buy Since 18-Sep-2021
$2
$0.21 (11.73%)
$10
1 years 19 days ago
(18-Sep-2025)
3/9 (33.33%)
$0.06 (3.09%)
97
What is IPHA (Innate Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on IPHA (Innate Pharma)?
Which analyst has the most public recommendations on IPHA (Innate Pharma)?
Which analyst is the currently most bullish on IPHA (Innate Pharma)?
Which analyst is the currently most reserved on IPHA (Innate Pharma)?
